The store will not work correctly when cookies are disabled.
2,6-Difluoro-3-{[4-(trifluoromethyl)benzyl]oxy}benzamide
ID: ALA5081697
PubChem CID: 166627877
Max Phase: Preclinical
Molecular Formula: C15H10F5NO2
Molecular Weight: 331.24
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NC(=O)c1c(F)ccc(OCc2ccc(C(F)(F)F)cc2)c1F
Standard InChI: InChI=1S/C15H10F5NO2/c16-10-5-6-11(13(17)12(10)14(21)22)23-7-8-1-3-9(4-2-8)15(18,19)20/h1-6H,7H2,(H2,21,22)
Standard InChI Key: GGLXMHUZYITWFX-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
25.0935 -11.2715 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.5157 -11.8534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3086 -12.0628 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.8559 -9.4100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8547 -10.2296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5628 -10.6385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2725 -10.2291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2696 -9.4064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5610 -9.0012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5586 -8.1840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2650 -7.7733 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8496 -7.7775 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9808 -10.6366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6879 -10.2269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3962 -10.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3929 -11.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1004 -11.8574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8084 -11.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8045 -10.6262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0964 -10.2225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9758 -8.9952 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.1481 -9.0016 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.5197 -12.6714 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
10 11 1 0
10 12 2 0
7 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
8 21 1 0
4 22 1 0
18 2 1 0
2 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.24 | Molecular Weight (Monoisotopic): 331.0632 | AlogP: 3.66 | #Rotatable Bonds: 4 |
Polar Surface Area: 52.32 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.97 | CX Basic pKa: ┄ | CX LogP: 3.55 | CX LogD: 3.55 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.87 | Np Likeness Score: -1.23 |
References
1. Huecas S, Araújo-Bazán L, Ruiz FM, Ruiz-Ávila LB, Martínez RF, Escobar-Peña A, Artola M, Vázquez-Villa H, Martín-Fontecha M, Fernández-Tornero C, López-Rodríguez ML, Andreu JM.. (2021) Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery., 64 (9.0): [PMID:33908781] [10.1021/acs.jmedchem.0c02207] |